Oil futures fell further on Wednesday after big declines the previous session with Brent sliding below US$40 a barrel for the first time since June as COVID-19 cases rebounded in several countries.
WASHINGTON: Three Republican U.S. senators on Tuesday introduced the latest legislation targeting a federal law that largely exempts tech platforms such as Facebook and Twitter from legal liability for the material their users post. The bill from Senator Roger Wicker, who chairs the Senate ...
SEOUL: You Young-sik has tried his luck running businesses, but when his convenience store, a sausage factory and a second-hand furniture shop all failed, he realised he had found a niche, one that he understood well: Helping people go out of business. You says he is now busier than...
SoftBank Group Corp shares fell 5per cent in early trading on Wednesday as investors worried about the Japanese conglomerate's exposure to U.S. tech stocks, which fell for the third straight session.
Gary Cohn, the former economic adviser to U.S. President Donald Trump, raised US$720 million on Tuesday in an initial public offering (IPO) for a new blank-check acquisition company, 20per cent more than originally planned, according to a person familiar with the matter.
Sportswear maker Under Armour said on Tuesday it will lay off about 600 employees from its global workforce, citing the impact brought on by the coronavirus pandemic to its business.
SoftBank Group Corp shares fell 5per cent in early trading on Wednesday as investors worried about the Japanese conglomerate's exposure to U.S. tech stocks, which fell for the third straight session.
Defense contractor Northrop Grumman Corp said on Tuesday it was awarded a US$13.3 billion contract by the US Air Force to modernize the country's intercontinental ballistic missile system.
Beyond Meat is looking to take a bite out of the massive Chinese market, announcing plans on Tuesday to produce its plant-based beef, pork and chicken in the Asian nation.
AstraZeneca Plc has put a hold on the late-stage trial of its highly-anticipated COVID-19 vaccine candidate after a suspected serious adverse reaction in a study participant, health news website Stat News reported on Tuesday.
